Sigma Planning Corp - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$420,000
+15.1%
2,781
+11.2%
0.02%
+23.1%
Q2 2022$365,000
-52.5%
2,502
-61.4%
0.01%
-43.5%
Q1 2022$769,000
-8.6%
6,486
+6.3%
0.02%0.0%
Q4 2021$841,000
-5.0%
6,100
-4.2%
0.02%
-14.8%
Q3 2021$885,000
+24.8%
6,368
-12.9%
0.03%
+28.6%
Q2 2021$709,000
+21.4%
7,308
-14.4%
0.02%
+10.5%
Q1 2021$584,000
-11.6%
8,537
+10.7%
0.02%
-13.6%
Q4 2020$661,000
-25.4%
7,710
-43.4%
0.02%
-37.1%
Q3 2020$886,000
-15.5%
13,623
-5.0%
0.04%
-23.9%
Q2 2020$1,049,000
+72.5%
14,343
-19.7%
0.05%
+27.8%
Q1 2020$608,000
-33.8%
17,856
+5.9%
0.04%
-7.7%
Q4 2019$918,000
+16.1%
16,868
-11.1%
0.04%
+2.6%
Q3 2019$791,000
-9.1%
18,968
-4.5%
0.04%
-15.6%
Q2 2019$870,000
+14.9%
19,868
+35.0%
0.04%
+4.7%
Q1 2019$757,000
+37.4%
14,716
-1.3%
0.04%
+7.5%
Q4 2018$551,000
+12.0%
14,908
+13.8%
0.04%
+37.9%
Q3 2018$492,000
-7.5%
13,101
-2.7%
0.03%
-19.4%
Q2 2018$532,000
+20.4%
13,461
-21.5%
0.04%
+12.5%
Q1 2018$442,000
+3.8%
17,141
+8.5%
0.03%
-3.0%
Q4 2017$426,000
-24.1%
15,803
+5.3%
0.03%
-28.3%
Q3 2017$561,00015,0030.05%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders